Detailed Narrative
Robust Q3 FY25 Performance and 9M Growth
Vishnu Chemicals reported strong financial results for Q3 FY25, with operating revenues growing 22% YoY to INR371 crores. Consolidated EBITDA surged 55% YoY to INR63 crores, achieving a 17% margin, while PAT increased 66% YoY to INR34 crores, with a 9.3% margin. For the nine months ended December 31, 2025, the company recorded operating revenues of INR1,053 crores, a 15% increase YoY, and a PAT of INR87 crores, up 20% YoY, demonstrating consistent sequential revenue growth despite a softer business environment.
Strategic Growth and Expansion in Barium Segment
The barium segment exhibited robust performance, with volumes increasing by 15-20% in Q3 FY25. Management is positive on achieving at least 15-20% volume growth in barium for FY26, driven by strong demand from the paint industry (growing 14% YoY) and opportunities in the US market due to competitor exits. The company is considering expanding its barium sulfate capacity towards the end of the current year, with the investment expected to fructify within two quarters, and aims for 80-85% capacity utilization in FY26.
Chromium Vertical Expansion and New Product Introduction
While chromium chemicals volume growth was limited in Q3 FY25, value increased by 5-6% due to price adjustments. The company plans to introduce chrome metal production in Q3 FY26, which is expected to be a value-accretive, import-replacement product. This initiative is projected to contribute an additional 10% volume growth in chromium and improve EBITDA margins towards H2 FY26, leveraging the current operating capacity of over 70,000 tons against an installed capacity of 82,000 tons.
Backward Integration and Raw Material Security
Vishnu Chemicals is enhancing its raw material security through strategic backward integration. The acquisition of Ramdas Minerals in July 2023, costing INR26 crores, has already recouped nearly 40% of its investment, with full recoupment expected within 2.5 years. The company has also signed definitive agreements for a chromium mine in South Africa, with reserves of 10 million tons, sufficient for 30 years. This mine, acquired for an initial investment of USD10 million, is expected to become operational within 1-2 quarters after regulatory approvals, ensuring long-term raw material supply.
New Product Development: Strontium Carbonate
A significant new product in the portfolio is strontium carbonate, which is targeted to be operational in Q1 FY26. The first phase capacity will be approximately 5,000 tons, addressing India's demand of 4,000-5,000 tons per annum. This import-substitute product targets lucrative markets such as electric motors, automobiles, zinc electrolysis plants, and ceramics, with top exporters to India currently being Mexico, Belgium, and Spain.
Jayansree Pharma Acquisition and Synergies
The acquisition of Jayansree Pharma for an enterprise value of INR52 crores (against a gross block of INR80 crores) was a strategic move to expedite new product launches. By investing an additional INR20-25 crores in capex, Vishnu Chemicals plans to restart operations to manufacture strontium carbonate within one quarter of acquisition. This approach offers significant time and cost advantages compared to a greenfield expansion, which would have required INR120 crores and four quarters.
Capital Allocation and Balance Sheet Strength
The company's balance sheet remains strong, supported by a CARE A- rating for its long-term facilities. A key development is the conversion of existing CCPS into equity shares, leading to an allotment of 17,88,089 equity shares to promoters at INR428.6 per share. This conversion is projected to reduce long-term borrowings by approximately INR76 crores by the end of the current financial year (FY25), further strengthening the company's financial position and demonstrating promoter commitment.